We look at Clover's key products, including SCB-2019 (COVID-19 vaccine), SCB-313 (for intracavitary malignancies), and SCB-808 (biosimilar of Enbrel with novel formulation).
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.